News
Below you will find links to various news.
For investor related and NASDAQ-regulated press releases, please go here.
Fuld fokus på terapeutisk vaccine
ExpreS2ion Biotechnologies is featured in a publication by Dansk Biotek today (in Danish). Our CEO, Bent Frandsen, presents one of […]
Company presentation
Check out ExpreS2ion Biotechnologies in this short video. Making a difference within oncology and infectious diseases – and we are […]
Science Talk: Fast-tracking of a COVID-19 vaccine development
Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of […]
ExpreS2ion is mentioned in Ingeniøren
Read full article here: https://ing.dk/artikel/danskere-vil-dyrke-coronavaccine-bananflueceller-232322
ExpreS2ion is mentioned in Nigerian Guardian
Read full article here: https://guardian.ng/interview/drug-shortage-imminent-if-coronavirus-epidemic-persists/
ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7
ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]
Upcoming Webinar: Developing an anti-HER2 breast cancer vaccine using advantageous Drosophila S2 cell protein expression and virus-like -particle display technologies
ExpreS2ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT […]
Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen
Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]
Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry
ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]
ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania
Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry
Expres2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “Biotekselskab og […]
The Francis Crick Institute Renews the Research License Agreement with ExpreS2ion Biotechnologies
Horsholm, Denmark, June 26, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
ExpreS2ion’s Chief Science Officer, Dr. Wian De Jongh, to Speak at World Biopharm Forum 2017 in Oxford, UK – June 27
Horsholm, Denmark, June 21, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
ExpreS2ion’s Chief Executive Officer, Dr. Steen Klysner, Speaks at Investordagen in Aarhus, Denmark – June 13
Horsholm, Denmark, June 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen
Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]
2021-10-27: Fuld fokus på terapeutisk vaccine
2020-10-12: ExpreS2ion skalar upp via emission
2020-10-06: ExpreS2ion storsatsar på egna vaccin
2020-09-03: Analysguiden raises its target price for ExpreS2ion to 24 SEK per share
2020-08-18: ExpreS2ion appoints new CFO
2020-08-03: ExpreS2ion announces exercise of 2017 warrant program
2020-07-17: This is how we produce difficult-to-express proteins
2020-07-14: ExpreS2ion’s platform to be used in a novel Zika vaccine candidate
2020-05-04: ExpreS2ion announces supporting an advantageous COVID-19 diagnostic antibody development project
2020-04-15: ExpreS2ion’s CSO Dr. Wian de Jongh co-signs WHO-sanctioned statement from 83 COVID-19 vaccine researchers
2020-03-20: ExpreS2ion Biotechnologies in light of the COVID-19 outbreak
2020-03-05: ExpreS2ion will present its ExpreS2 platform and pipeline at several key events in March and April 2020
2020-01-23: ExpreS2ion’s CEO in interview on 2019 and the company’s new way forward with a stronger pipeline focus
2020-01-21: ExpreS2ion is streamlining its market communication with English as primary language